Primary |
Restless Legs Syndrome |
68.4% |
Product Used For Unknown Indication |
10.0% |
Neuropathy Peripheral |
4.2% |
Neuralgia |
2.6% |
Fibromyalgia |
2.1% |
Urinary Incontinence |
1.6% |
Blood Pressure |
1.1% |
Epilepsy |
1.1% |
Migraine Prophylaxis |
1.1% |
Pain |
1.1% |
Periodic Limb Movement Disorder |
1.1% |
Post Herpetic Neuralgia |
1.1% |
Sleep Apnoea Syndrome |
1.1% |
Anxiety |
0.5% |
Back Pain |
0.5% |
Blood Potassium |
0.5% |
Hypersomnia |
0.5% |
Hypertension |
0.5% |
Muscle Spasms |
0.5% |
Musculoskeletal Disorder |
0.5% |
|
Somnolence |
14.9% |
Drug Ineffective |
13.8% |
Dizziness |
12.8% |
Insomnia |
6.4% |
Adverse Event |
5.3% |
Feeling Abnormal |
5.3% |
Suicidal Ideation |
5.3% |
Therapeutic Response Unexpected |
5.3% |
Restless Legs Syndrome |
4.3% |
Sedation |
4.3% |
Therapeutic Response Decreased |
3.2% |
Abnormal Dreams |
2.1% |
Asthenia |
2.1% |
Constipation |
2.1% |
Drug Intolerance |
2.1% |
Hypersomnia |
2.1% |
Hypomania |
2.1% |
Limb Injury |
2.1% |
Nausea |
2.1% |
Oedema Peripheral |
2.1% |
|
Secondary |
Restless Legs Syndrome |
71.4% |
Depression |
9.5% |
Rhinitis Allergic |
9.5% |
Feeling Jittery |
4.8% |
Product Used For Unknown Indication |
4.8% |
|
Drug Ineffective |
16.7% |
Feeling Jittery |
16.7% |
Hangover |
16.7% |
Restless Legs Syndrome |
16.7% |
Skin Discolouration |
16.7% |
Somnolence |
16.7% |
|
Concomitant |
Product Used For Unknown Indication |
43.0% |
Multiple Sclerosis |
15.1% |
Restless Legs Syndrome |
10.5% |
Dry Eye |
4.7% |
Hypersensitivity |
4.7% |
Open Angle Glaucoma |
2.3% |
Psoriasis |
2.3% |
Psoriatic Arthropathy |
2.3% |
Rheumatoid Arthritis |
2.3% |
Anxiety |
1.2% |
Asthma |
1.2% |
Blood Triglycerides Increased |
1.2% |
Breast Cyst |
1.2% |
Chronic Obstructive Pulmonary Disease |
1.2% |
Depression |
1.2% |
Diabetes Mellitus |
1.2% |
Gastrooesophageal Reflux Disease |
1.2% |
Hypertension |
1.2% |
Hypothyroidism |
1.2% |
Insomnia |
1.2% |
|
Scleral Hyperaemia |
28.6% |
Sinusitis |
14.3% |
Benign Uterine Neoplasm |
7.1% |
Hyperhidrosis |
7.1% |
Nausea |
7.1% |
Nervousness |
7.1% |
Peripheral Coldness |
7.1% |
Rash Erythematous |
7.1% |
Rash Generalised |
7.1% |
Restless Legs Syndrome |
7.1% |
|